- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03185975
Providing Online Counseling for Home-Based HIV Testing With Transgender Youth
18. oktober 2019 opdateret af: Robert Stephenson, University of Michigan
This research study will recruit 200 transgender youths between the ages of 15-24.
There are two arms to the research study: the control and the intervention arm.
Each eligible participant will be randomized into either arm.
The control arm participants receive an OraQuick HIV testing kit sent to an address of their choice and instructions of how to conduct the test.
They will enter their results on the research study website and complete surveys at 3 month intervals until an entire year has passed.
Participants in the intervention arm will receive an OraQuick HIV testing kit sent to them and will receive video-based counseling called Motivational Interviewing and Certified Testing and Referral.
After this counseling session, the results from the OraQuick HIV test will be logged by study staff.
Then, participants in the intervention arm will fill out surveys at 3 month intervals until a year has passed.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
200
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 49109
- University of Michigan Center for Sexuality and Health Disparities
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
15 år til 24 år (Barn, Voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- male sex at birth, identifies as female, trans feminine, trans woman, female
- female sex at birth, identifies as male, trans male, trans masculine, male
- agender, genderfluid, genderqueer
- between the ages of 15-24,
- negative or unknown HIV status and not having tested in the least 3 months
- willingness to have HIV test kit delivered to an address they provide
- wilingness to be tested for HIV
- willingness to be randomized to either study arm
- willingness and ability to participate in video-based counseling (must have a computer or tablet with video and audio capabilities, internet access)
Exclusion Criteria:
- same sex assigned at birth and currently identifies as that same sex
- aged 14 years or younger, or 25 years or older
- reports having a positive HIV status during the baseline survey or screener survey before testing unwillingness to have HIV test kit delivered to an address they provide
- unwillingness to test for HIV
- unwillingness to be randomized
- unwillingness or inability to participate in video-based counseling
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Placebo komparator: Control arm
Each participant will receive an at-home test kit and will be asked to test and return results to investigator.
|
Transgender youth in the control arm will receive test kits, but will not receive any testing intervention.
Once individual results are reported, participants will be contacted via phone or email by study staff with options for referrals to services.
Participants will complete follow-up surveys at 3, 6, 9, and 12 months post-testing.
|
|
Aktiv komparator: Intervention Arm
Each participant will receive an at-home test kit and will be asked to take the test in conjunction with an online Motivational interviewing/certified testing and referral (MI/CTR).
|
Transgender individuals randomized to the experimental group (MI/CTR) will receive HIV counseling and testing via an online, HIPPA-compliant videoconferencing service.
The session will last less than one hour and focus on HIV testing, prevention strategies, and/or linkage to HIV care, depending on the individual's test results.
Participants will complete follow up surveys at 3, 6, 9 and 12 months.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Increase uptake of HIV testing for transgender youth
Tidsramme: 1 year
|
Assess differences and changes in TY's sexual-risk behaviors between those who receive the home-testing with video-based MI/CTR (intervention arm) compared to those who receive the home-testing alone (control arm).
200 TY (100 male: 100 female) will be randomized to either the intervention or control arm and followed for 6 months with surveys taken at baselines and months 3, 6, 9 and 12 months.
|
1 year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Sexual Behavior
Tidsramme: 1 year.
|
We measure changes in sexual behavior using behavioral measures based on information collected from the baseline survey, MI/CTR session for the intervention arm participants, and subsequent surveys each 3 months until one year from the initial survey has occurred.
|
1 year.
|
|
Linkage to Care
Tidsramme: 1 year
|
We will measure linkage to care with the following outcomes as indicators per the recent recommendations of the Institute of Medicine and CDC: within 3 months of HIV diagnosis, attending at least one clinical care appointment, having at least one CD4 test performed and having at least one viral load test performed.
|
1 year
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Rob Stephenson, PhD, University of Michigan Center for Sexuality & Health Disparities
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Stephenson R, Todd K, Kahle E, Sullivan SP, Miller-Perusse M, Sharma A, Horvath KJ. Project Moxie: Results of a Feasibility Study of a Telehealth Intervention to Increase HIV Testing Among Binary and Nonbinary Transgender Youth. AIDS Behav. 2020 May;24(5):1517-1530. doi: 10.1007/s10461-019-02741-z.
- Stephenson R, Metheny N, Sharma A, Sullivan S, Riley E. Providing Home-Based HIV Testing and Counseling for Transgender Youth (Project Moxie): Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2017 Nov 28;6(11):e237. doi: 10.2196/resprot.8562.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
19. juni 2017
Primær færdiggørelse (Faktiske)
30. september 2019
Studieafslutning (Faktiske)
30. september 2019
Datoer for studieregistrering
Først indsendt
11. juni 2017
Først indsendt, der opfyldte QC-kriterier
11. juni 2017
Først opslået (Faktiske)
14. juni 2017
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
21. oktober 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
18. oktober 2019
Sidst verificeret
1. oktober 2019
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- HUM00123412
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hiv
-
Duke UniversityGilead SciencesRekrutteringHIV-forebyggelse | HIV præ-eksponeringsprofylakse | HIV forebyggelsesprogram | HIV-forebyggelse og pleje | HIV Pre-eksponering profylakse brugForenede Stater
-
Federal University of São PauloGilead SciencesAfsluttet
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekrutteringHIV | HIV-testning | HIV-kobling til pleje | HIV behandlingForenede Stater
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RekrutteringForbered | HIV | HIV-forebyggelse | PrEP optagelseForenede Stater
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RekrutteringHIV-forebyggelse | PrEP overholdelse | HIV-relateret stigmaThailand
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationAfsluttetPartner HIV-testning | Par HIV Rådgivning | Parkommunikation | HIV-forekomstCameroun, Dominikanske republik, Georgien, Indien
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RekrutteringGennemførlighed | HIV-forebyggelse | PrEP optagelse | Acceptabilitet | HIV Selvtest | Mandlige partnere af HIV-negative postpartum-kvinderSydafrika
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement og andre samarbejdspartnereUkendtHIV | HIV-uinficerede børn | Børn udsat for HIVCameroun
-
Instituto Mexicano del Seguro SocialRekrutteringVægttab | HIV | HIV-1 infektion | Vægtændring | HIV-associeret vægttab | Integrasehæmmere, HIV; HIV PROTEASE HÆMMERMexico
-
University of MinnesotaTrukket tilbageHIV-infektioner | HIV/AIDS | Hiv | AIDS | Aids/Hiv problem | AIDS og infektionerForenede Stater
Kliniske forsøg med at-home test kit
-
National University, SingaporeNational University Hospital, SingaporeAfsluttet
-
Stanford UniversityBIOBOXAfsluttet
-
Mahidol UniversityChulalongkorn University; Ministry of Health, Thailand; Yuvabadhana foundation og andre samarbejdspartnereAfsluttetCoronavirus infektioner | Covid19 | SARS-CoV-2 | FællesskabstransmissionerThailand
-
ReCode TherapeuticsSano Genetics; ReverbaAktiv, ikke rekrutterendePrimær ciliær dyskinesiForenede Stater
-
Great Ormond Street Hospital for Children NHS Foundation...University College, LondonUkendtCystisk fibrose | Cystisk fibrose-relateret diabetesDet Forenede Kongerige
-
Assistance Publique - Hôpitaux de ParisCommissariat A L'energie Atomique; NG BiotechIkke rekrutterer endnuNosokomielle infektioner | Candida Auris infektion | Candida Auris-kolonisering
-
Arion BioCSSi Life SciencesAfsluttet
-
AccessBio, Inc.Afsluttet
-
Foundation for Innovative New Diagnostics, SwitzerlandAfsluttet